Recombinant Tissue Plasminogen Activator (rtPA) Injection 52.5mg is a thrombolytic (clot-dissolvi
Recombinant Tissue Plasminogen Activator (rtPA) Injection 52.5mg is a thrombolytic (clot-dissolving) medication primarily used to treat blood clots in medical emergencies. It mimics the natural tissue plasminogen activator, which helps break down blood clots by converting plasminogen into plasmin, the enzyme responsible for clot dissolution.
Acute Ischemic Stroke:
Acute Myocardial Infarction (Heart Attack):
Pulmonary Embolism:
Deep Vein Thrombosis (DVT) and Other Arterial/Vein Blockages:
Related products